Pharma Marketing Network

This article describes recent dark and ominous

This article explores the trend in direct-to-consumer (DTC) ads for 'breakthrough' cancer therapies.

This article summarizes the First Amendment assault on FDA's ability to regulate off-label communications.

Welcome to Vol. 15, Issue No. 4 (September 2016) of Pharma Marketing News. This issue focuses on off-label promotions directed to consumers, dark and scary disease awareness advertising, and breakthrough cancer therapy DTC.

When STATnews reporter Rebecca Robbins (@rebeccadrobbins) interviewed me about what's behind ominous unbranded "disease awareness" ads, I opined that if you’re a drug maker,...

Welcome to the August 30, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

Welcome to the December 13, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

This survey attempts to get feedback from the Pharma Marketing Network community on several questions relating to the drug industry's sponsorship of FREE, ACCME accredited continuing medical education (CME) for physicians.

This surevy solicits your opinion on the benefits of pharma access to prescribing information, physicians ability to opt-out, and appropriate uses of Rx data by pharmaceutical companies.

Some people would like to see DTC ads play a more educational role.